CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2020 EXECUTIVE SUMMARY

被引:406
作者
Garber, Alan J. [1 ,2 ]
Handelsman, Yehuda [3 ]
Grunberger, George [4 ,5 ,6 ,7 ,8 ]
Einhorn, Daniel [9 ,10 ,11 ]
Abrahamson, Martin J. [12 ,13 ]
Barzilay, Joshua, I [14 ,15 ]
Blonde, Lawrence [16 ]
Bush, Michael A. [17 ,18 ]
DeFronzo, Ralph A. [19 ,20 ]
Garber, Jeffrey R. [21 ]
Garvey, W. Timothy [22 ,23 ,24 ]
Hirsch, Irl B. [25 ]
Jellinger, Paul S. [8 ,26 ,27 ]
McGill, Janet B. [28 ]
Mechanick, Jeffrey, I [8 ,29 ,30 ,31 ,32 ,33 ,34 ]
Perreault, Leigh [35 ]
Rosenblit, Paul D. [36 ,37 ,38 ]
Samson, Susan [39 ,40 ,41 ]
Umpierrez, Guillermo E. [42 ]
机构
[1] Baylor Coll Med, Dept Med Biochem & Mol Biol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[3] Metab Inst Amer, AACE Lipid & Cardiovasc Hlth Dis State Network, Tarzana, CA USA
[4] Wayne State Univ, Sch Med, Grunberger Diabet Inst, Detroit, MI 48202 USA
[5] Wayne State Univ, Sch Med, Internal Med & Mol Med & Genet, Detroit, MI 48202 USA
[6] Oakland Univ, William Beaumont Sch Med, Internal Med, Rochester, MI 48063 USA
[7] Charles Univ Prague, Fac Med 1, Internal Med, Prague, Czech Republic
[8] Amer Assoc Clin Endocrinologists, 245 Riverside Ave,Suite 200, Jacksonville, FL 32202 USA
[9] UCSD, Scripps Whittier Diabet Inst, La Jolla, CA USA
[10] UCSD, Med, La Jolla, CA USA
[11] Diabet & Endocrine Associates, La Jolla, CA USA
[12] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA
[13] Harvard Med Sch, Boston, MA 02115 USA
[14] Emory Univ, Sch Med, Div Endocrinol Kaiser Permanente Georgia, Atlanta, GA USA
[15] Emory Univ, Sch Med, Div Endocrinol, Atlanta, GA USA
[16] Ochsner Med Ctr, Ochsner Diabet Clin Res Unit, Frank Ridclic Diabet Inst, Dept Endocrinol, New Orleans, LA USA
[17] UCLA, Cedars Sinai Med Ctr, Div Endocrinol, Los Angeles, CA 90048 USA
[18] UCLA, Geffen Sch Med, Med, Los Angeles, CA USA
[19] Univ Texas Hlth Sci Ctr San Antonio, Med, San Antonio, TX 78229 USA
[20] Univ Texas Hlth Sci Ctr San Antonio, Diabet Div, San Antonio, TX 78229 USA
[21] Beth Israel Deaconess Med Ctr, Endocrine Div, Harvard Vanguard Med Associates, Div Endocrinol, Boston, MA 02215 USA
[22] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA
[23] UAB Diabet Res Ctr, Birmingham, AL USA
[24] Birmingham VAMC, Birmingham, AL USA
[25] Univ Washington, Sch Med, Med, Seattle, WA USA
[26] Univ Miami, Miller Sch Med, Clin Med, Miami, FL 33136 USA
[27] Ctr Diabet & Endocrine Care, Hollywood, FL USA
[28] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, Med, St Louis, MO USA
[29] Icahn Sch Med Mt Sinai, Med, New York, NY 10029 USA
[30] Icahn Sch Med Mt Sinai, Marie Josee & Henry R Kravis Ctr Clin Cardiovasc, New York, NY 10029 USA
[31] Icahn Sch Med Mt Sinai, Metab Support, Div Cardiol & Endocrinol, New York, NY 10029 USA
[32] Icahn Sch Med Mt Sinai, Metab Support, Div Diabet, New York, NY 10029 USA
[33] Icahn Sch Med Mt Sinai, Metab Support, Div Bone Dis, New York, NY 10029 USA
[34] Amer Coll Endocrinol, Jacksonville, FL USA
[35] Univ Colorado, Sch Med, Med, Denver, CO USA
[36] Univ Calif Irvine, Sch Med, Med, Div Endocrinol,Diabet,Metab, Irvine, CA 92717 USA
[37] UCI Med Ctr, Diabet Out Patient Clin, Orange, CA USA
[38] Diabet Lipid Management & Res Ctr, Huntington Beach, CA USA
[39] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
[40] Baylor Coll Med, Pituitary Ctr, Houston, TX 77030 USA
[41] Baylor Coll Med, Endocrinol Fellowship Program, Houston, TX 77030 USA
[42] Emory Univ, Sect Head Diabet & Endocrinol, Med, Grady Hlth Syst, Atlanta, GA 30322 USA
关键词
CORONARY-HEART-DISEASE; TO-TARGET TRIAL; RANDOMIZED CONTROLLED-TRIAL; CONTROLLED-RELEASE PHENTERMINE/TOPIRAMATE; DENSITY-LIPOPROTEIN CHOLESTEROL; CONVERTING-ENZYME-INHIBITOR; IMPAIRED GLUCOSE-TOLERANCE; COMBINATION LIPID THERAPY; TERM DIETARY INTERVENTION; IMPROVES GLYCEMIC CONTROL;
D O I
10.4158/CS-2019-0472
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This document represents the official position of the American Association of Clinical Endocrinologists and American College of Endocrinology. Where there were no randomized controlled trials or specific U.S. FDA labeling for issues in clinical practice, the participating clinical experts utilized their judgment and experience. Every effort was made to achieve consensus among the committee members. Position statements are meant to provide guidance, but they are not to be considered prescriptive for any individual patient and cannot replace the judgment of a clinician. Copyright © 2020 AACE.
引用
收藏
页码:107 / 139
页数:33
相关论文
共 291 条
  • [1] Efficacy of Colesevelam on Lowering Glycemia and Lipids
    Aggarwal, Saurabh
    Loomba, Rohit S.
    Arora, Rohit R.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2012, 59 (02) : 198 - 205
  • [2] Acute coronary syndromes and diabetes: is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trial
    Ahmed, Shaheeda
    Cannon, Christopher P.
    Murphy, Sabina A.
    Braunwald, Eugene
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (19) : 2323 - 2329
  • [3] Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin - diabetes control and potential adverse events
    Ahren, Bo
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (04) : 487 - 498
  • [4] Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
    Allison, David B.
    Gadde, Kishore M.
    Garvey, William Timothy
    Peterson, Craig A.
    Schwiers, Michael L.
    Najarian, Thomas
    Tam, Peter Y.
    Troupin, Barbara
    Day, Wesley W.
    [J]. OBESITY, 2012, 20 (02) : 330 - 342
  • [5] Anxiety and poor glycemic control: A meta-analytic review of the literature
    Anderson, RJ
    Grigsby, AB
    Freedland, KE
    de Groot, M
    McGill, JB
    Clouse, RE
    Lustman, PJ
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 2002, 32 (03) : 235 - 247
  • [6] The prevalence of comorbid depression in adults with diabetes - A meta-analysis
    Anderson, RJ
    Freedland, KE
    Clouse, RE
    Lustman, PJ
    [J]. DIABETES CARE, 2001, 24 (06) : 1069 - 1078
  • [7] [Anonymous], INVOKANA CANAGLIFLOZ
  • [8] [Anonymous], FARX DAP PRESCR INF
  • [9] [Anonymous], STEGL ERT PRESCR INF
  • [10] [Anonymous], FDA REV WARN REG US